Current Studies
Please get in touch with our Research department for further information regarding participating in a clinical trial. Lake Cumberland Rheumatology’s Research department can be reached by email at [email protected] or by phone by dialing (502) 351-6983.
The LC Rheumatology staff that are a part of the research team include:
A Randomized, Double-Blind, Placebo-Controlled Phase 4 Clinical Trial to Evaluate the Long-Term Safety and Efficacy of Avacopan in Subjects With Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis
Participants must be:
- 18 years of age or older
- diagnosed with ANCA Vasculitis
A Randomized, Double-Blind, Parallel Group Placebo[1] Controlled Multicenter Phase 3 Study to Evaluate Efficacy, Safety, and Tolerability of Two Regiments of Ianalumab on Top of Standard-Of-Care Therapy with Patients with Systematic Lupus Erythematosus (SIRIUS-SLE 1)
Participants must be:
- 18 years of age or older
- diagnosed with Systemic Lupus Erythematosus for at least 6 months before screening
Prospective, Multi-Center, Observational, Whole Blood Specimen Collection Study in Participants with Rheumatoid Arthritis with inadequate response or intolerance to a DMARD Starting a New bDMARD or tsDMARD Treatment +/- csDMARD
Participants must be:
-
18 years or older, diagnosed with Rheumatoid Arthritis
-
Currently on medication for Rheuamtoid Arthritis but planning to start a new medication.
A Study to Investigate Effectiveness of Tirzepatide in Clinical Practice following Initiation of Ixekizumab in Participants with Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice
Participants must be:
- 18 years or older, diagnosed with Psoriatic Arthritis.
- BMI of 30 and treated with Taltz for 3 months, able to start Zepbound (cannot have any prior exposure to Zepbound/Mounjaro/Wegovy/Trulicity/Victoza).